Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

Episode 3 June 09, 2021 00:39:48
Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

Jun 09 2021 | 00:39:48

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be discussing insights into market research solutions for rare diseases with Danielle Drayton, PhD, CEO of REACH Market Research.

Other Episodes

Episode 14

November 10, 2021 00:46:16
Episode Cover

Episode 14: Bo Bigelow, Chairman at the Foundation for USP7-Related Diseases, and Trish Flanagan, President at the Yellow Brick Road Project

How will a rare disease diagnosis affect your family? Today's Few & Far Between episode features Bo Bigelow, Chairman at the Foundation for USP7-Related...

Listen

Episode 5

July 07, 2021 00:51:14
Episode Cover

Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development...

Listen

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen